Abstract: Provided is a drug combination for prevention and/or treatment of tumors. The drug combination includes: a) an ascorbic acid or a derivative thereof in an amount effective for prevention and/or treatment, and b) a selective PDE4 inhibitor in an amount effective for prevention and/or treatment.

Abstract: A flexible photoelectric device module and a method for preparing same are provided. The module includes a plurality of photoelectric device units. One photoelectric device unit includes a bottom electrode, a functional layer and a top electrode. The bottom electrode includes a light-transmittance insulating base, and a first electrode, a second electrode and a third electrode which are arranged on two side surfaces of the base. The first electrode is a transparent electrode. The second electrode and the first electrode are in electric contact with each other. The second electrode and the third electrode are electrically connected through a conducting channel. The conducting channel runs through the base along a thickness direction. The third electrode in one photoelectric device unit is electrically connected to the top electrode or the first electrode in another photoelectric device unit, so that the two photoelectric device units are disposed in series or in parallel.

Abstract: An antenna module, comprising: a substrate; at least one first antenna array, located on the substrate, comprising at least one first antenna and having a first maximum radiation direction; and at least one second antenna array, located on the substrate, comprising at least one second antenna and having a second maximum radiation direction. A communication device using the antenna module is also disclosed.

Abstract: A fingerprint detection array substrate is provided. The fingerprint detection array substrate includes a plurality of touch electrode blocks in a plurality of touch detection regions configured to detect a touch position, wherein touch electrode blocks in a respective one of the plurality of touch detection regions are inter-connected through bridges, forming a touch electrode unit, and the touch electrode unit is isolated from touch electrode blocks in adjacent touch detection regions of the plurality of touch detection regions; a plurality of touch signal lines configured to respectively transmit touch signals to a plurality of touch detection regions, wherein a respective one of the plurality of touch signal lines is electrically connected to the touch electrode unit limited in the respective one of the plurality of touch detection regions; and a fingerprint sensor configured to perform fingerprint sensing limited in a fingerprint scanning region.

Abstract: Two-part silane modified polymer/free radically curable adhesive systems demonstrating improved strength and percent elongation are provided.

Abstract: Provided is an antibody molecule that binds to human Nectin-4 or a fragment thereof. The antibody is obtained by means of hybridoma screening and humanization techniques, and is used for the prevention or treatment of a cancer, and may be used as a clinical lead drug molecule.

Abstract: Embodiments of the present disclosure provide an antibody that binds to human Claudin 18.2 or a fragment thereof, as well as encoded nucleic acids and the like thereof. The anti-human Claudin 18.2 antibody of embodiments of the present disclosure has strong affinity to an antigen Claudin 18.2 and significant complement-dependent cytotoxicity (CDC) activity and antibody-dependent cytotoxicity (ADCC) activity to target expression cells, and exhibits high specificity to human CLDN 18.2.

Abstract: This disclosure provides a test kit for testing a device under test (DUT) including a socket structure for containing the DUT, and a plunger assembly detachably coupled with the socket structure. The plunger assembly includes a multi-layered structure having a nest and an interposer substrate installed under the nest.

Abstract: A robotic arm device includes a robotic arm including a base, a first arm and a second arm, a wire set adjacent to the first arm and the second arm, and a wire take-up module set in the first arm and including a rail, a sliding block and an elastic member. The sliding block is vertically slidably set on the rail and connected with the wire set and the elastic member. With the configuration of the wire take-up module, the robotic arm device can achieve the effects of improving wiring convenience, reducing wiring interference and saving wiring time.

Abstract: A robotic arm device includes a robotic arm including a base, a first arm and a second arm, a wire set adjacent to the first arm and the second arm, and a wire take-up module set in the first arm and including a rail, a sliding block and an elastic member. The sliding block is vertically slidably set on the rail and connected with the wire set and the elastic member. With the configuration of the wire take-up module, the robotic arm device can achieve the effects of improving wiring convenience, reducing wiring interference and saving wiring time.

Abstract: A semiconductor package structure is provided. The structure includes a package substrate having a first surface and a second surface opposite to the first surface and including a ground layer embedded therein. A semiconductor die is formed on the first surface of the package substrate and an antenna pattern layer is formed on the second surface of the package substrate and electrically coupled to the semiconductor die. The structure also includes a first connector and a second connector formed on the second surface of the package substrate and arranged adjacent to the antenna pattern layer. The first connector is electrically coupled to the semiconductor die and electrically isolated to the ground layer, and the second connector is electrically coupled to the ground layer. A wireless communication device including the semiconductor package structure is also provided.

Abstract: The invention relates to a liquid formulation of humanized antibody for treating IL-6 related diseases. The liquid formulation contains 2-100 mg/ml recombinant humanized anti-human interleukin 6 receptor monoclonal antibody, 5-20 mM histidine salt buffer (or a buffer of a combination of 5-20 mM histidine salt and 5-20 mM sodium acetate), 0.025-0.075% (by volume) surfactant, and 3-5% (by mass to volume) stabilizer and water for injection. The antibody formulation enhances the stability of the recombinant anti-human interleukin 6 receptor monoclonal antibody, prevents the monoclonal antibody from aggregation, degradation, and acidic isomer increases. This formulation can be used for stabilizing the structure and function of the humanized antibody.

Abstract: A pharmaceutical combination for preventing and/or treating cancer and a kit. The pharmaceutical combination comprises: a) a prophylactically and/or therapeutically effective amount of ascorbic acid or a derivative thereof, and b) a prophylactically and/or therapeutically effective amount of a substance, such as PKF118-130, NCB-0846, PRI-724, siRNA484, siRNA1202, siRNA1387, a compound C-1, and a compound C-2, affecting the formation of a TCF/?-catenin complex.

Abstract: A retaining ring can be shaped by machining or lapping the bottom surface of the ring to form a shaped profile in the bottom surface. The bottom surface of the retaining ring can include flat, sloped and curved portions. The lapping can be performed using a machine that dedicated for use in lapping the bottom surface of retaining rings. During the lapping the ring can be permitted to rotate freely about an axis of the ring. The bottom surface of the retaining ring can have curved or flat portions.

Abstract: A fingerprint detection array substrate is provided. The fingerprint detection array substrate includes a plurality of touch electrode blocks in a plurality of touch detection regions configured to detect a touch position, wherein touch electrode blocks in a respective one of the plurality of touch detection regions are inter-connected through bridges, forming a touch electrode unit, and the touch electrode unit is isolated from touch electrode blocks in adjacent touch detection regions of the plurality of touch detection regions; a plurality of touch signal lines configured to respectively transmit touch signals to a plurality of touch detection regions, wherein a respective one of the plurality of touch signal lines is electrically connected to the touch electrode unit limited in the respective one of the plurality of touch detection regions; and a fingerprint sensor configured to perform fingerprint sensing limited in a fingerprint scanning region.

Abstract: An anti-TNF-? antibody formulation, and a preparation method and use of the anti-TNF-? antibody is disclosed. The anti-TNF-? antibody formulation, preparation method, and use relates to the field of pharmacy. The formulation includes an anti-TNF-? antibody and a pharmaceutically acceptable carrier. The anti-TNF-? antibody includes a heavy chain with an amino acid sequence set forth in SEQ ID NO: 1 and a light chain with an amino acid sequence set forth in SEQ ID NO: 2. The pharmaceutically acceptable carrier includes a stabilizer, a surfactant and a buffer. The disclosed antibody formulation has high stability and does not support microorganism growth.

Abstract: The present disclosure provides an electric hair clipper with a temperature changing function, including a machine body and a cutter head, a heat transfer structure for heating and refrigerating is disposed in the machine body, and the heat transfer structure and the fixed cutter fixing member are connected to each other in a manner of heat conduction; or a refrigerating structure is disposed in the machine body, which is connected to the fixed cutter fixing member in a manner of heat conduction; or a heating structure is disposed in the machine body, which is connected to the fixed cutter fixing member in a manner of heat conduction. The heat transfer structure and the fixed cutter fixing member are connected to each other in a manner of heat conduction, so that the temperature of the fixed cutter fixing member can change directly, and the overall heat transfer energy loss is small.

Abstract: The present application relates to a pharmaceutical combination, comprising: a) a prophylactically and/or therapeutically effective amount of ascorbic acid or a derivative thereof; and b) a prophylactically and/or therapeutically effective amount of a second therapeutic agent selected from the group consisting of: a Notch signaling pathway inhibitor, an HH signaling pathway inhibitor, a Porcupine inhibitor, an RXR? inhibitor, Niclosamide, a CK1a inhibitor, and a Frizzled receptor inhibitor.

Abstract: The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, U, W1, W2, W3, R1-R6, and R9 are described herein.

Abstract: The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes.